Free Trial
NASDAQ:TOI

Oncology Institute (TOI) Stock Price, News & Analysis

Oncology Institute logo
$2.46 +0.03 (+1.02%)
Closing price 07/3/2025 03:55 PM Eastern
Extended Trading
$2.47 +0.01 (+0.20%)
As of 07/3/2025 04:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Oncology Institute Stock (NASDAQ:TOI)

Key Stats

Today's Range
$2.40
$2.54
50-Day Range
$2.05
$3.31
52-Week Range
$0.13
$3.50
Volume
813,014 shs
Average Volume
1.12 million shs
Market Capitalization
$219.96 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.00
Consensus Rating
Buy

Company Overview

Oncology Institute Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
28th Percentile Overall Score

TOI MarketRank™: 

Oncology Institute scored higher than 28% of companies evaluated by MarketBeat, and ranked 2413th out of 2,814 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Oncology Institute has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Oncology Institute has only been the subject of 1 research reports in the past 90 days.

  • Read more about Oncology Institute's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Oncology Institute is -3.52, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Oncology Institute is -3.52, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Oncology Institute has a P/B Ratio of 49.30. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Oncology Institute's valuation and earnings.
  • Percentage of Shares Shorted

    5.88% of the float of Oncology Institute has been sold short.
  • Short Interest Ratio / Days to Cover

    Oncology Institute has a short interest ratio ("days to cover") of 1.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Oncology Institute has recently increased by 54.49%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Oncology Institute does not currently pay a dividend.

  • Dividend Growth

    Oncology Institute does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    5.88% of the float of Oncology Institute has been sold short.
  • Short Interest Ratio / Days to Cover

    Oncology Institute has a short interest ratio ("days to cover") of 1.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Oncology Institute has recently increased by 54.49%, indicating that investor sentiment is decreasing significantly.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Oncology Institute this week, compared to 2 articles on an average week.
  • Search Interest

    4 people have searched for TOI on MarketBeat in the last 30 days. This is an increase of 33% compared to the previous 30 days.
  • MarketBeat Follows

    Only 1 people have added Oncology Institute to their MarketBeat watchlist in the last 30 days. This is a decrease of -67% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Oncology Institute insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $13,379,013.00 in company stock.

  • Percentage Held by Insiders

    Only 8.50% of the stock of Oncology Institute is held by insiders.

  • Percentage Held by Institutions

    Only 36.86% of the stock of Oncology Institute is held by institutions.

  • Read more about Oncology Institute's insider trading history.
Receive TOI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oncology Institute and its competitors with MarketBeat's FREE daily newsletter.

TOI Stock News Headlines

Special gold investment soars 2,300% ... 5,090% ... 9,850%
In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rally right now. Over the past few weeks alone, the yellow metal surged as high as $3,500 — the highest level on record. So far this bull run playing out exactly as me and my analysts have predicted.
See More Headlines

TOI Stock Analysis - Frequently Asked Questions

Oncology Institute's stock was trading at $0.3090 at the start of the year. Since then, TOI shares have increased by 697.7% and is now trading at $2.4650.

The Oncology Institute, Inc. (NASDAQ:TOI) issued its earnings results on Wednesday, May, 14th. The company reported ($0.18) EPS for the quarter. The company had revenue of $104.41 million for the quarter. Oncology Institute had a negative net margin of 15.38% and a negative trailing twelve-month return on equity of 445.02%.
Read the conference call transcript
.

Shares of TOI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Oncology Institute investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Arista Networks (ANET), Adobe (ADBE), AppLovin (APP) and CrowdStrike (CRWD).

Company Calendar

Last Earnings
5/14/2025
Today
7/04/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Services
Sub-Industry
Healthcare
Current Symbol
NASDAQ:TOI
Fax
N/A
Employees
660
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$7.00
High Stock Price Target
$7.00
Low Stock Price Target
$7.00
Potential Upside/Downside
+184.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$64.66 million
Pretax Margin
-15.96%

Debt

Sales & Book Value

Annual Sales
$403.15 million
Price / Cash Flow
N/A
Book Value
$0.05 per share
Price / Book
49.30

Miscellaneous

Free Float
81,649,000
Market Cap
$219.96 million
Optionable
Not Optionable
Beta
0.02
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:TOI) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners